Relapsed or Advanced Non-small Cell Lung Cancer
1 clinical trials · Condition
◉ Watch Relapsed or Advanced Non-small Cell Lung Cancer
| Record | Firm | Date |
|---|---|---|
| Phase Ib/II Study of Almonertinib Combined With SHR-1701 in the Treatment of Relapsed or Advanced Non-small Cell Lung Cancer (NCT05503888) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2022-10-01 |
Track Relapsed or Advanced Non-small Cell Lung Cancer automatically
Every clearance here is in the API, with alerts when new ones post.